Corient Private Wealth’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Sell |
176,707
-10,926
| -6% | -$1.17M | 0.02% | 439 |
|
|
2025
Q1 | $18.9M | Buy |
187,633
+17,097
| +10% | +$1.72M | 0.03% | 397 |
|
|
2024
Q4 | $15.2M | Buy |
170,536
+2,097
| +1% | +$187K | 0.03% | 436 |
|
|
2024
Q3 | $14.1M | Sell |
168,439
-2,533
| -1% | -$212K | 0.02% | 465 |
|
|
2024
Q2 | $13.2M | Buy |
170,972
+12,087
| +8% | +$931K | 0.02% | 464 |
|
|
2024
Q1 | $10.9M | Buy |
158,885
+3,027
| +2% | +$207K | 0.02% | 505 |
|
|
2023
Q4 | $9.01M | Sell |
155,858
-22,948
| -13% | -$1.33M | 0.02% | 543 |
|
|
2023
Q3 | $9.44M | Buy |
178,806
+3,776
| +2% | +$199K | 0.02% | 493 |
|
|
2023
Q2 | $9.47M | Buy |
175,030
+16,506
| +10% | +$893K | 0.02% | 486 |
|
|
2023
Q1 | $7.93M | Buy |
158,524
+23,265
| +17% | +$1.16M | 0.02% | 469 |
|
|
2022
Q4 | $6.26M | Buy |
+135,259
| New | +$6.26M | 0.02% | 446 |
|